Search research articles
Contact Us
Filters
Showing results (151-160 of 178) with videos related to
Page
of 18
Sort By:
Bone Marrow Transplantation
|
June 2, 2015
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT
J R Passweg, M Labopin, J Cornelissen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2003
Therapy-related acute promyelocytic leukemia
M Beaumont, M Sanz, P M Carli, et al.
Leukemia
|
January 17, 2013
A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse
S Park, N Chapuis, F Saint Marcoux, et al.
Bone Marrow Transplantation
|
September 15, 2015
In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?
R Peffault de Latour, M Labopin, J Cornelissen, et al.
Blood
|
May 16, 1998
A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM)
F Witz, A Sadoun, M C Perrin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 7, 2014
The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party
I El-Najjar, A Boumendil, J J Luan, et al.
Bone Marrow Transplantation
|
June 18, 1998
Allogeneic stem cell transplantation for Fanconi Anaemia. Severe Aplastic Anaemia Working Party of the EBMT and EUFAR. European Group for Blood and Marrow Transplantation
P Guardiola, G Socié, R Pasquini, et al.
British Journal of Haematology
|
August 1, 1996
Treatment of acute myelogenous leukaemia in patients aged 50-65: idarubicin is more effective than zorubicin for remission induction and prolonged disease-free survival can be obtained using a unique consolidation course. The Goelam Group
B Pignon, F Witz, B Desablens, et al.
Bone Marrow Transplantation
|
March 7, 1998
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia
J R Passweg, P Tiberghien, J Y Cahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2004
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group
S de Botton, A Fawaz, S Chevret, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 178) with videos related to
Sort By:
Page
of 18
Bone Marrow Transplantation
|
June 2, 2015
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT
J R Passweg, M Labopin, J Cornelissen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2003
Therapy-related acute promyelocytic leukemia
M Beaumont, M Sanz, P M Carli, et al.
Leukemia
|
January 17, 2013
A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse
S Park, N Chapuis, F Saint Marcoux, et al.
Bone Marrow Transplantation
|
September 15, 2015
In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?
R Peffault de Latour, M Labopin, J Cornelissen, et al.
Blood
|
May 16, 1998
A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM)
F Witz, A Sadoun, M C Perrin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 7, 2014
The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party
I El-Najjar, A Boumendil, J J Luan, et al.
Bone Marrow Transplantation
|
June 18, 1998
Allogeneic stem cell transplantation for Fanconi Anaemia. Severe Aplastic Anaemia Working Party of the EBMT and EUFAR. European Group for Blood and Marrow Transplantation
P Guardiola, G Socié, R Pasquini, et al.
British Journal of Haematology
|
August 1, 1996
Treatment of acute myelogenous leukaemia in patients aged 50-65: idarubicin is more effective than zorubicin for remission induction and prolonged disease-free survival can be obtained using a unique consolidation course. The Goelam Group
B Pignon, F Witz, B Desablens, et al.
Bone Marrow Transplantation
|
March 7, 1998
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia
J R Passweg, P Tiberghien, J Y Cahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2004
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group
S de Botton, A Fawaz, S Chevret, et al.
Page
of 18